Lazard Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145K | Buy |
+6,344
| New | +$145K | ﹤0.01% | 1774 |
|
|
2025
Q1 | – | Sell |
-1,630
| Closed | -$60K | – | 2295 |
|
|
2024
Q4 | $60K | Sell |
1,630
-5,771
| -78% | -$212K | ﹤0.01% | 1933 |
|
|
2024
Q3 | $358K | Sell |
7,401
-78
| -1% | -$3.77K | ﹤0.01% | 1464 |
|
|
2024
Q2 | $298K | Sell |
7,479
-1,538
| -17% | -$61.3K | ﹤0.01% | 1429 |
|
|
2024
Q1 | $395K | Sell |
9,017
-180
| -2% | -$7.89K | ﹤0.01% | 1108 |
|
|
2023
Q4 | $568K | Buy |
9,197
+10
| +0.1% | +$618 | ﹤0.01% | 1077 |
|
|
2023
Q3 | $422K | Buy |
9,187
+2,491
| +37% | +$114K | ﹤0.01% | 1195 |
|
|
2023
Q2 | $383K | Buy |
6,696
+2,637
| +65% | +$151K | ﹤0.01% | 1181 |
|
|
2023
Q1 | $152K | Sell |
4,059
-1,974
| -33% | -$73.9K | ﹤0.01% | 1386 |
|
|
2022
Q4 | $169K | Buy |
6,033
+702
| +13% | +$19.7K | ﹤0.01% | 1333 |
|
|
2022
Q3 | $149K | Buy |
5,331
+1,288
| +32% | +$36K | ﹤0.01% | 1340 |
|
|
2022
Q2 | $140K | Buy |
4,043
+2,126
| +111% | +$73.6K | ﹤0.01% | 1382 |
|
|
2022
Q1 | $68K | Buy |
1,917
+71
| +4% | +$2.52K | ﹤0.01% | 1578 |
|
|
2021
Q4 | $42K | Buy |
+1,846
| New | +$42K | ﹤0.01% | 1813 |
|
|
2021
Q3 | – | Sell |
-3,479
| Closed | -$70K | – | 2144 |
|
|
2021
Q2 | $70K | Buy |
+3,479
| New | +$70K | ﹤0.01% | 1460 |
|
|
2021
Q1 | – | Sell |
-2,861
| Closed | -$57K | – | 1842 |
|
|
2020
Q4 | $57K | Buy |
2,861
+405
| +16% | +$8.07K | ﹤0.01% | 1338 |
|
|
2020
Q3 | $46K | Buy |
+2,456
| New | +$46K | ﹤0.01% | 1206 |
|
|
2020
Q1 | – | Sell |
-1,812
| Closed | -$34K | – | 1571 |
|
|
2019
Q4 | $34K | Buy |
1,812
+695
| +62% | +$13K | ﹤0.01% | 1134 |
|
|
2019
Q3 | $22K | Buy |
+1,117
| New | +$22K | ﹤0.01% | 1059 |
|